The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 55 | — | 20.1x | Near average | |
Growth | 84 | 129.0% | 5.6% | Above average | |
Quality | 43 | -25.6% | 7.6% | Near average | |
Safety | 44 | 2.3x | 0.4x | Near average | |
Capital Return | 20 | 0.00% | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Tarsus Pharmaceuticals, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Tarsus Pharmaceuticals, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Tarsus Pharmaceuticals (TARS) stock shows a state of complete stability in analyst estimates over the (7 and 30-day) timeframes, with the average price target holding steady at 84 dollars. This consistency reflects the absence of any recent revisions by analysts, with a notable positive price gap between the current price (62.26 dollars) and the lowest observed price target (68 dollars), indicating underlying optimism despite the limited number of analysts participating in the current coverage.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.